The Evolving State of Relapsed/Refractory Multiple Myeloma Treatment

San Antonio, Texas
Thursday, April 28, 2016

You are invited to attend a CNE satellite symposium to be held during the Oncology Nursing Society’s (ONS) 41st Annual Congress. 

6:00 PM – 7:30 PM
Dinner/Scientific Program

Activity Overview
In 2015 four new agents were approved for the treatment of multiple myeloma (MM) in the salvage setting, equipping oncology health professionals with more therapeutic options than ever before. But for oncology nurses, this progress also brings the challenge of managing new treatment-related toxicities. This interactive symposium will feature the use of iPads to provide current information to help oncology nurses maximize treatment outcomes for patients with relapsed/refractory MM.

Target Audience
This activity has been designed to meet the educational needs of oncology nurses, advanced oncology certified nurse practitioners, and other health care professionals involved in the care of patients with MM.

Learning Objectives
At the conclusion of this activity, participants should be able to:
  • Distinguish between the indicated uses, mechanisms of action, and safety of current and emerging agents for patients with relapsed/refractory MM
  • Describe the toxicity profile for agents commonly used for the treatment of patients with relapsed/refractory MM
  • Create patient-centered management plans with patients and other members of the care team to minimize the impact of treatment-related side effects
  • Demonstrate how incorporating patient education and communication strategies can improve early detection of treatment-related adverse events
Accreditation Statement
University of Texas Health Science Center at San Antonio is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Credit Designation
This activity has been planned and implemented using the educational design criteria of the ANCC Commission on Accreditation through the joint providership of University of Texas Health Science Center at San Antonio and the other providers; 1.4 CNE contact hours will be awarded for participation in this symposium.

Access Statement

RedMedEd complies fully with the legal requirements of the Americans With Disabilities Act. If you are in need of special accommodation, please contact Barbara Zosh via e-mail at bzosh@redmeded.com.

Jointly provided by


Support for this activity has been provided through educational grants from Amgen, Bristol-Myers Squibb, and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.

Meeting space has been assigned to provide a symposium supported through educational grants by Amgen, Bristol-Myers Squibb, and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC during the Oncology Nursing Society’s (ONS) 41st Annual Congress, April 28–May 1, 2016 in San Antonio, Texas. The Oncology Nursing Society's assignment of meeting space does not imply product endorsement.
 

Contact Information

© 2019
Quick, easy and affordable online event registration and event management software for all event sizes.